75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS total debt 1999–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Sanofi ADS's total debt was 19.85B EUR on 30 September 2026, down 8.8% on a year before. At the end of fiscal year 2025 it was 20.33B EUR.
Last updated 9 Nov 2026 · Next report 4 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 19.85B | -8.78% | 5.97B | -13.88B | 0.27 |
| FY2025 | 31 Dec 2025 | 20.33B | +13.53% | 8.47B | -11.86B | 0.28 |
| FY2024 | 31 Dec 2024 | 17.91B | -4.23% | 7.93B | -9.98B | 0.23 |
| FY2023 | 31 Dec 2023 | 18.70B | -11.86% | 8.71B | -9.99B | 0.25 |
| FY2022 | 31 Dec 2022 | 21.21B | -5.36% | 12.74B | -8.48B | 0.28 |
| FY2021 | 31 Dec 2021 | 22.41B | -5.33% | 10.10B | -12.32B | 0.33 |
| FY2020 | 31 Dec 2020 | 23.68B | -8.71% | 13.92B | -9.76B | 0.38 |
| FY2019 | 31 Dec 2019 | 25.93B | +5.25% | 9.74B | -16.19B | 0.44 |
| FY2018 | 31 Dec 2018 | 24.64B | +57.94% | 6.93B | -17.72B | 0.42 |
| FY2017 | 31 Dec 2017 | 15.60B | -16.03% | 10.32B | -5.29B | 0.27 |
| FY2016 | 31 Dec 2016 | 18.58B | +12.23% | 10.38B | -8.20B | 0.32 |
| FY2015 | 31 Dec 2015 | 16.55B | +11.75% | 9.25B | -7.31B | 0.29 |
| FY2014 | 31 Dec 2014 | 14.81B | +1.54% | 7.56B | -7.26B | 0.26 |
| FY2013 | 31 Dec 2013 | 14.59B | +0.41% | 8.44B | -6.15B | 0.26 |
| FY2012 | 31 Dec 2012 | 14.53B | -5.88% | 6.56B | -7.97B | 0.25 |
| FY2011 | 31 Dec 2011 | 15.44B | +86.91% | 2.10B | -13.34B | 0.27 |
| FY2010 | 31 Dec 2010 | 8.26B | -6.42% | 5.82B | -2.44B | 0.16 |
| FY2009 | 31 Dec 2009 | 8.83B | +46.97% | 4.97B | -3.86B | 0.18 |
| FY2008 | 31 Dec 2008 | 6.01B | +1.09% | 4.63B | -1.38B | 0.13 |
| FY2007 | 31 Dec 2007 | 5.94B | -14.44% | 1.79B | -4.15B | 0.13 |
| FY2006 | 31 Dec 2006 | 6.94B | -37.86% | 1.26B | -5.68B | 0.15 |
| FY2005 | 31 Dec 2005 | 11.18B | -30.34% | 1.56B | -9.62B | 0.24 |
| FY2004 | 31 Dec 2004 | 16.04B | +4,263.56% | 2.49B | -13.55B | 0.39 |
| FY2003 | 31 Dec 2003 | 367.64M | -11.72% | 3.37B | 3.00B | 0.06 |
| FY2002 | 31 Dec 2002 | 416.45M | +3.08% | 3.09B | 2.67B | 0.07 |
| FY2001 | 31 Dec 2001 | 404.00M | -1.94% | 4.29B | 3.89B | 0.07 |
| FY2000 | 31 Dec 2000 | 412.00M | -10.63% | 2.88B | 2.47B | 0.10 |
| FY1999 | 31 Dec 1999 | 461.00M | — | 2.36B | 1.90B | 0.13 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 19.85B | -8.78% | 5.97B | -13.88B | 0.27 |
| Q2 FY2026 | 30 Jun 2026 | 23.58B | +5.79% | 6.35B | -17.23B | 0.34 |
| Q1 FY2026 | 31 Mar 2026 | 20.02B | -4.87% | 5.54B | -14.48B | 0.27 |
| Q4 FY2025 | 31 Dec 2025 | 20.33B | +13.53% | 8.47B | -11.86B | 0.28 |
| Q3 FY2025 | 30 Sept 2025 | 21.76B | — | 8.91B | -12.85B | 0.30 |
| Q2 FY2025 | 30 Jun 2025 | 22.29B | -7.26% | 15.36B | -6.93B | 0.32 |
| Q1 FY2025 | 31 Mar 2025 | 21.05B | — | 7.99B | -13.06B | 0.28 |
| Q4 FY2024 | 31 Dec 2024 | 17.91B | -4.23% | 7.93B | -9.98B | 0.23 |
| Q2 FY2024 | 30 Jun 2024 | 24.03B | +14.28% | 6.80B | -17.24B | 0.33 |
| Q1 FY2024 | 31 Mar 2024 | 0.00 | — | 8.71B | 8.71B | 0.00 |
| Q4 FY2023 | 31 Dec 2023 | 18.70B | -11.86% | 8.71B | -9.99B | 0.25 |
| Q3 FY2023 | 30 Sept 2023 | 0.00 | — | 7.99B | 7.99B | 0.00 |
| Q2 FY2023 | 30 Jun 2023 | 21.03B | -0.99% | 7.99B | -13.03B | 0.29 |
| Q1 FY2023 | 31 Mar 2023 | 0.00 | — | 12.74B | 12.74B | 0.00 |
| Q4 FY2022 | 31 Dec 2022 | 21.21B | -5.36% | 12.74B | -8.48B | 0.28 |
| Q3 FY2022 | 30 Sept 2022 | 0.00 | — | 6.90B | 6.90B | 0.00 |
| Q2 FY2022 | 30 Jun 2022 | 21.24B | -1.90% | 6.90B | -14.34B | 0.30 |
| Q1 FY2022 | 31 Mar 2022 | 0.00 | — | 10.11B | 10.11B | 0.00 |
| Q4 FY2021 | 31 Dec 2021 | 22.41B | -5.33% | 10.10B | -12.32B | 0.33 |
| Q3 FY2021 | 30 Sept 2021 | 0.00 | — | 9.72B | 9.72B | 0.00 |
| Q2 FY2021 | 30 Jun 2021 | 21.65B | -13.15% | 9.72B | -11.93B | 0.34 |
| Q1 FY2021 | 31 Mar 2021 | 0.00 | — | 13.92B | 13.92B | 0.00 |
| Q4 FY2020 | 31 Dec 2020 | 23.68B | -8.71% | 13.92B | -9.76B | 0.38 |
| Q3 FY2020 | 30 Sept 2020 | 0.00 | — | 15.97B | 15.97B | 0.00 |
| Q2 FY2020 | 30 Jun 2020 | 24.93B | -6.62% | 15.97B | -8.96B | 0.39 |
| Q1 FY2020 | 31 Mar 2020 | 0.00 | — | 9.43B | 9.43B | 0.00 |
| Q4 FY2019 | 31 Dec 2019 | 25.93B | +5.25% | 9.74B | -16.19B | 0.44 |
| Q3 FY2019 | 30 Sept 2019 | 0.00 | — | 6.74B | 6.74B | 0.00 |
| Q2 FY2019 | 30 Jun 2019 | 26.70B | -7.76% | 6.74B | -19.95B | 0.47 |
| Q1 FY2019 | 31 Mar 2019 | 0.00 | -100.00% | 6.96B | 6.96B | 0.00 |
| Q4 FY2018 | 31 Dec 2018 | 24.64B | +57.94% | 6.93B | -17.72B | 0.42 |
| Q3 FY2018 | 30 Sept 2018 | 0.00 | — | 7.49B | 7.49B | 0.00 |
| Q2 FY2018 | 30 Jun 2018 | 28.94B | +57.06% | 7.49B | -21.45B | 0.51 |
| Q1 FY2018 | 31 Mar 2018 | 27.00B | — | 12.80B | -14.20B | 0.46 |
| Q4 FY2017 | 31 Dec 2017 | 15.60B | -16.03% | 10.45B | -5.15B | 0.27 |
| Q3 FY2017 | 30 Sept 2017 | 0.00 | — | 10.88B | 10.88B | 0.00 |
| Q2 FY2017 | 30 Jun 2017 | 18.43B | +6.66% | 10.88B | -7.55B | 0.32 |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | — | 10.31B | 10.31B | 0.00 |
| Q4 FY2016 | 31 Dec 2016 | 18.58B | +12.23% | 10.41B | -8.17B | 0.32 |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | — | 6.21B | 6.21B | 0.00 |
| Q2 FY2016 | 30 Jun 2016 | 17.28B | +17.28% | 6.08B | -11.20B | 0.32 |
| Q1 FY2016 | 31 Mar 2016 | 0.00 | — | 9.20B | 9.20B | 0.00 |
| Q4 FY2015 | 31 Dec 2015 | 16.55B | +11.75% | 9.25B | -7.31B | 0.29 |
| Q3 FY2015 | 30 Sept 2015 | 0.00 | — | 4.93B | 4.93B | 0.00 |
| Q2 FY2015 | 30 Jun 2015 | 14.73B | -0.43% | 4.93B | -9.81B | 0.26 |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | — | 7.45B | 7.45B | 0.00 |
| Q4 FY2014 | 31 Dec 2014 | 14.81B | +1.54% | 7.56B | -7.26B | 0.26 |
| Q3 FY2014 | 30 Sept 2014 | 0.00 | — | 4.37B | 4.37B | 0.00 |
| Q2 FY2014 | 30 Jun 2014 | 14.80B | +0.93% | 4.37B | -10.42B | 0.29 |
| Q1 FY2014 | 31 Mar 2014 | 0.00 | — | 8.34B | 8.34B | 0.00 |
| Q4 FY2013 | 31 Dec 2013 | 14.59B | +0.41% | 8.44B | -6.15B | 0.26 |
| Q3 FY2013 | 30 Sept 2013 | 0.00 | — | 4.26B | 4.26B | 0.00 |
| Q2 FY2013 | 30 Jun 2013 | 14.66B | -9.41% | 4.26B | -10.40B | 0.26 |
| Q1 FY2013 | 31 Mar 2013 | 0.00 | — | 6.48B | 6.48B | 0.00 |
| Q4 FY2012 | 31 Dec 2012 | 14.53B | -5.88% | 6.56B | -7.97B | 0.25 |
| Q2 FY2012 | 30 Jun 2012 | 16.18B | -19.26% | 4.64B | -11.54B | 0.29 |
| Q4 FY2011 | 31 Dec 2011 | 15.44B | +86.91% | 4.16B | -11.28B | 0.27 |
| Q2 FY2011 | 30 Jun 2011 | 20.04B | +109.49% | 6.65B | -13.39B | 0.38 |
| Q4 FY2010 | 31 Dec 2010 | 8.26B | -6.42% | 6.49B | -1.77B | 0.16 |
| Q2 FY2010 | 30 Jun 2010 | 9.57B | -3.55% | 3.40B | -6.17B | 0.18 |
| Q4 FY2009 | 31 Dec 2009 | 8.83B | +46.97% | 4.97B | -3.86B | 0.18 |
| Q2 FY2009 | 30 Jun 2009 | 9.92B | +51.56% | 6.40B | -3.52B | 0.22 |
| Q4 FY2008 | 31 Dec 2008 | 6.01B | +1.09% | 4.63B | -1.38B | 0.13 |
| Q2 FY2008 | 30 Jun 2008 | 6.54B | -1.76% | 946.82M | -5.60B | 0.16 |
| Q4 FY2007 | 31 Dec 2007 | 5.94B | -14.45% | 1.79B | -4.15B | 0.13 |
| Q2 FY2007 | 30 Jun 2007 | 6.66B | -33.07% | 1.18B | -5.48B | 0.14 |
| Q4 FY2006 | 31 Dec 2006 | 6.94B | -37.81% | 1.26B | -5.68B | 0.15 |
| Q2 FY2006 | 30 Jun 2006 | 9.95B | -33.71% | 1.51B | -8.44B | 0.22 |
| Q4 FY2005 | 31 Dec 2005 | 11.17B | -30.34% | 1.56B | -9.61B | 0.24 |
| Q2 FY2005 | 30 Jun 2005 | 15.01B | +4,547.98% | 2.72B | -12.29B | 0.34 |
| Q4 FY2004 | 31 Dec 2004 | 16.03B | +4,260.44% | 2.49B | -13.54B | 0.39 |
| Q2 FY2004 | 30 Jun 2004 | 323.02M | +5.29% | 3.21B | 2.89B | 0.05 |
| Q4 FY2003 | 31 Dec 2003 | 367.64M | -11.72% | 3.37B | 3.00B | 0.06 |
| Q2 FY2003 | 30 Jun 2003 | 306.80M | -32.12% | 2.27B | 1.96B | 0.05 |
| Q4 FY2002 | 31 Dec 2002 | 416.45M | — | 3.09B | 2.67B | 0.07 |
| Q2 FY2002 | 30 Jun 2002 | 451.96M | — | 3.04B | 2.59B | 0.08 |
Figures in EUR at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet
Common questions about Sanofi ADS's debt
Source: Financial Modeling Prep